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A  reductionist approach is commonly used to gain insight into complex biological 
systems: individual components of the system are isolated so that the contribution of 
each individual element can be studied in detail. Dissection of the events that control 
blood clotting (1) or complement activation (2, 3)  are examples of the successful use 
of this approach. 
We  have  tried to use  this approach  to understand  the highly complex system of 
immunoregulation. Our strategy has depended on the demonstration that the genetic 
program of many immunologically competent cells combines information for function 
(reflected  by  the  synthesis  of  biologically  active  proteins  by  the  cells)  with  the 
expression  of  an  unique  pattern  of  surface  glycoproteins  (4).  These  celt  surface 
glycoproteins can  serve as markers  for fractionating lymphocytes into sets with  the 
use of specific antisera and the contribution of each set to the regulation of immunity 
can then be determined. 
This experimental approach has shown that cells which express the Ly-1+,2  -  T  cell 
set surface pattern (Ly-1 cells)  ~ are programmed to act as inducer or initiator cells. All 
T-dependent  immune  responses  so  far  studied  require  induction  by  Ly-1  cells  for 
optimal  activity  (4,  5);  Ly-1  cells  induce  B  cells  to  make  antibody;  they  induce 
macrophages and other nonspecific inflammatory cells to participate in delayed-type 
hypersensitivity reactions; they induce effector activity from killer cell precursors; and 
they  induce  suppressor  T  cells  to  express  optimal  suppression.  Whether  all  these 
inducing  functions  of the  Ly-1  cell  set  are  invested  in  a  single  group  of cells, or, 
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whether the Ly-1 set is a heterogeneous collection of cells with each inducer function 
being mediated by individual Ly-1 subsets is not fully resolved. 
The use of antisera against  a  polymorphic gene product(s)  controlled  by the  I-J 
subregion of the major histocompatibility complex (6)  has given a  partial answer to 
this question (7). Thus, Ly-1 cells treated with anti-I-J serum and complement induce 
B ceils to secrete antibody but are deficient in their ability to induce suppressor cell 
activity, i.e., the I-J  + Ly- 1 subset is specialized in inducing suppressive activity whereas 
cells  in  the  I-J-;  Ly-12 subset  are  specialized  in  inducing  B  cell  activity  (7).  This 
finding indicates that not all inducer activities are equally invested in all Ly-1 cells. 
Less information is available on the heterogeneity of regulatory T  cells that express 
the  Ly-l-,Ly-2  +  phenotype  (Ly-2  cells).  Tada  et  al  (8)  have  shown  that  an  I-J  + 
fraction of Ly-2 cells is dependent  upon an interaction with I-J+;Lyhl+; Ly-2  +  (Ly- 
1,2)  cells to manifest suppressive activity. This requirement  for Ly-1,2 cells to make 
Ly-2 suppressor cell activity manifest has also been demonstrated  by Germain and 
Benacerraf (9)  and McDougal et al.  (10).  The precise cell surface phenotype of the 
final  effector cell  in  these  systems has  not  been  determined.  On  the  other  hand, 
Kontiainen and Feldmann  (11)  have shown that Ly-2 cells can suppress the in vitro 
antibody response of cultured spleen cells that have been depleted of all Ly-2  + (Ly-2 
and Ly-1,2) cells, suggesting that the Ly-2 cell set may also be heterogeneous. 
These considerations led us to attempt to separate and characterize those Ly-2 T 
cells that act as suppressor cells in the presence of Ly-l,2 T  cells from those acting as 
suppressor cells in their absence.  In the course of these studies, we have found that 
regulatory  Ly-2  T  cells  can  be  subdivided  into  I-J  +  and  I-J-  fractions.  The  I-J- 
fraction contains effector cells that suppress Ly-1 helper T  cell activity.  3 Within the 
I-J  + fraction there is a  subset of cells that has not been previously described. These 
cells  interact  with  Ly-l,2 T  cells to  inhibit  Ly-2-mediated suppressor cell  activity. 
This report concerns the definition of this heretofore unrecognized immunoregulatory 
circuit which is composed of at least two T  cell subsets that communicate via the use 
of a cell free product. We use the term "contrasuppression" to define the immunoreg- 
ulatory activity that this cellular circuit produces. 
Materials and Methods 
Mice.  C57BL/6J  (B6), (C57BL/6  X B10.A)F1 (B6AFa), and B10.A/Sn  mice, 8-12 wk of 
age, were obtained from The Jackson Laboratory, Bar Harbor, Maine. All other strains are 
maintained in our colony at Yale University School of Medicine, New Haven, Conn. 
Antigens.  Sheep erythrocytes (SRBC)  were obtained from Colorado Serum Co.,  Denver, 
Colo. 
Antisera.  Anti-Ly-l.2 (C3H/An anti-C3H.CE-Lyt-l.2) and anti-Ly-2.2 (C3H/An × B6-Lyt- 
2.1  anti-ERLD) were prepared and tested for specificity  as previously described (12). Mono- 
clonal anti-Thy-1 reagents were generously provided by Dr. Phillip Lake, University College, 
London  and  Dr. Jonathan  Sprent,  University of Pennsylvania,  Philadelphia,  Pa.  Anti-I-J  b 
serum was prepared by hyper-immunizing B10.A(5R)  recipients with a mixture of B10.A(3R) 
spleen  and lymph node cells (antiserum No. ASM-5).  Anti-I-J  k sera were prepared by hyper- 
2 The designation "I-J-" is used to indicate that the cell type in question is not killed by complement- 
dependent treatment with our anti-I-J reagents. We cannot exclude the possibility that these I-J- functional 
cell  populations  (a)  express an  I-J  determinant  not  detected by our reagents or  (b)  express insufficient 
amounts of I-J antigen to be killed. 
3 Although it is clear that I-J+;Ly-2 T  cells are involved in the generation of suppressor activity, there 
is no previously published evidence that I-J-controlled  determinants are expressed on Ly-2 effector cells 
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immunizing B10.A(3R)  (antisera No. ASM-18 and No. AMS-19) and [B10.A(3R) ×  A.BY]FI 
(ASM-46) recipients with B10.A(SR) cells (6). 
Cytotoxic Depletion of Cells.  Depletion  of cells bearing a  given  marker  was  achieved  by 
incubating cells with antiserum diluted in balanced salt solution (BSS) for 30 min at 37°C  (1 
×  107 cells/1 ml of 1:20-diluted anti-Ly sera/1 ml of l:l,000-diluted anti-Thy-1 serum/1 ml of 
l:5-diluted anti-I-J serum), washing, and incubating with rabbit complement for 45  min at 
37°C (1 ×  107 cells/1 ml of l:10-diluted complement). The cells were then washed twice in BSS 
and resuspended in tissue culture medium (13). 
Preparation of Lymphocyte Subpopulations.  T  cells were prepared by adding unprimed spleen 
cells to plastic petri dishes coated with goat anti-mouse immunoglobulin, and harvesting the 
nonadherent  fraction (14).  B cells were prepared by treating unprimed spleen cells with anti- 
Thy-l.2 plus complement  (13).  Depletion of Ly-2-bearing T  cells from unprimed spleen cell 
suspensions was achieved by treating spleen cells with anti-Ly-2.2 plus complement  (Ly-1 T 
cells plus B cells) (13). 
Antiserum Absorption.  Absorption of the  B10.A(3R)  anti-B10.A(5R)  serum  (ASM-18)  was 
performed by suspending 1 ml of l:5-diluted serum with 3 ×  108 unprimed spleen plus lymph 
node cells for 1 h at room temperature. 
Antigen Stimulation ofLy-2 T Cells.  Ly-2 T cells were primed by culturing 1 ml of 107 purified 
T  cells with 0.025  ml of a  1% sheep erythrocytes (SRBC) suspension for 4 d  in Falcon 3008 
tissue culture dishes (Falcon Labware, Div. of Becton, Dickenson, & Co., Oxnard, Calif.) in a 
5% CO2-95% air incubator at 37°C. RPMI-1640 tissue culture media, fortified with 10% fetal 
calf serum (FCS), 100 mM glutamine, 25 mM Hepes, and 5 ×  10  -8 M  2-mercaptoethanol was 
used. After the 4-d culture period, the cells were harvested, washed, counted, treated with anti- 
Ly-1 plus complement, and added in graded numbers to appropriate assay cultures (13, 15). 
Assay Cultures.  Suppressor activity by the primed Ly-2 T  cells was determined by adding 
these cells to cultures containing either unprimed spleen cells or anti-Ly-2 plus complement- 
treated unprimed spleen cells (Ly-1 T cells plus B cells) plus or minus additional, unfractionated 
unprimed T  cells. Helper activity was determined by adding unprimed T  cells to anti-Thy-1 
plus complement-treated unprimed spleen cells (B  cell source). All cells were suspended in 
RPMI-1640 tissue culture medium (see above), and 0.2 ml of the cells cultured with 0.025 ml 
of a  1% SRBC suspension in Falcon 3040 flat-bottomed microtiter trays (cell assays) or 1 ml of 
the cells cultured with 0.05 ml of a  I% SRBC suspension in Falcon 3008 plates (factor assays) 
in a 5% CO2-95%  air incubator at 37°C. At day 5, the anti-SRBC response was determined by 
enumerating  the  number  of plaque-forming  cells  (PFC)  per  culture  by  the  technique  of 
Cunningham and Szenberg (16). 
Purification ofLy-2 T Suppressor Factor.  The detailed method for production of this factor has 
been described.  4 Mice were immunized intraperitoneally with 0.2 ml of 20% SRBC twice at a 
2-wk interval and killed 2 wk after the second immunization. Their spleen cells were treated 
with an anti-Ly-1 serum and rabbit complement (C') and then cultivated in vitro for 48 h at 
1 ×  107/ml in RPMI-1640 supplemented with 10% FCS. 
After incubation, the supernate was harvested, centrifuged at  2,500  rpm  for 20  rain and 
passed through  a  Millipore filter (Millipore Corp., Bedford, Mass.).  (The role of antigen in 
helping ]or suppressing] the production of these factors has not yet been fully determined). 
Results 
Definition of a  T  Cell Subset that Interferes with  Ly-2 Suppressor T  Cell Activity  (Surface 
Phenotype Thy-1 ÷;Ly-1 +,2+;I-J +)  (Table I).  Under appropriate experimental condi- 
tions, antigen-primed Ly-2 T  cells will only suppress Ly-1 T  cell helper activity in the 
absence ofunprimed Ly-2  + T  cells. Data from three experiments (Table I) demonstrate 
that the ability of 3 ×  104 SRBC-primed Ly-2 T  cells to suppress responses by 2 ×  106 
unprimed anti-Ly-2 plus C'-treated spleen cells (Ly-1 T  and B  cells)  (Table I, line  1 
4 Yamauchi,  K., D. B. Murphy, F.-W. Shen, H. Cantor, and R. K. Gershon. Analysis of "I-J-" MHC- 
restricted, cell-free products  from "I-J-";Ly-2 T cell that suppress Ly-2-depleted spleen cells. Manuscript 
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TABLE  I 
Definition of a  T  Cell Subset  That Interferes  with Ly-2 Suppressor  T  Cell Activity  (Surface  Phenotype: 
4.  at.  4-  +  Thy-I  ;Ly-I  ,2  ;I-J  ) 
3  ×  10  4 
primed  2 X 10  5 unprimed T 
Ly-2 T  cells treated with:~ 
cells* 
10  s unprimed Ly-1 T 
and B cells§ 
B10.A  BI0.A  B6 
(Exp.  (Exp.  (Exp. 
I)  If)  III) 
Comments 
PFC/ culture 
1.  -  No cells added  2,500  1,700  1,500  Control.  Ly-1 T cells induce B cells to 
produce antibody. 
2.  +  No ceils added  500  100  500  Suppression.  Primed Ly-2 T cells sup- 
press helper activity. 
3.  +  NMSII  +  C'  2,600  1,600  1,500  No suppression.  Unprimed T  cells in- 
terfere with suppressor  activity. 
4.  +  Anti-I-J  k (I) +  C'  600  100  Suppression.  anti-I-J  k  kills  unprimed 
T cells that interfere with suppressor 
activity. 
5.  +  Anti-Thy-1 (II) +  C'  800  Suppression.  Anti-Thy-1  kills  un- 
primed  T  cells  that  interfere with 
suppressor  activity. 
6.  +  Mixture I +  II  800  Suppression.  I-J  and  Thy-I  determi- 
nants  are  both  expressed  on  un- 
primed  T  cells  that  interfere with 
suppressor  activity. 
7.  +  Anti-Ly-2 +  C'  700  Suppression.  Anti-Ly-2 kills unprimed 
T cells that interfere with suppressor 
activity (suppression  not overcome 
by additional Ly-1 T cells). 
8.  +  Anti-Ly-1  +  C'  400  Suppression.  anti-Ly-1  kills unprimed 
T cells that interfere with suppressor 
activity. 
9.  +  Anti-IoJk+ C'  1,600  No  suppression.  Anti-I-J  k fails  to  kill 
unprimed T  cells that intefere with 
suppressor  activity  in  I-J  b  strain 
(specificity control). 
10.  +  Anti-I-J  b + C'  600  Suppression.  Demonstration  that  an 
unprimed I-J T  cell interferes  with 
suppressor  activity in H-2  b mice. 
*  Ig-plate-nonadherent spleen cells cultured for 4 d with SRBC and treated with anti-Ly-1  plus C'. 
Ig-plate-nonadherent spleen cells. Anti-I-J  k, B 10.A(3R) anti-B 10.A(5R)  (ASM- 19); anti-I-J  b, B 10.A(5R) 
anti-B 10.A(3R)  (ASM-5). 
6  t  § All cultures contain 10  anti-Ly-2 plus C -treated unprimed spleen cells (Ly-1 T cells and B cells). Mean 
PFC of triplicate cultures.  B 10.A (I-jk), B6 (I-Jb). 
11 NMS, normal mouse serum. 
vs. line 2), can be blocked by the addition of 2  ×  10  5 unprimed  T  cells to the cultures 
(line 3).  Identical  results were obtained  using cells from two different  inbred  strains, 
B 10.A  (experiment  I  and  experiment  II)  and  B6  (experiment  III). Thus,  cells present 
in  the  antigenically  naive  T  cell  preparation  interfered  with  Ly-2  T  cell-mediated 
suppression,  i.e., displayed  contrasuppressive  activity.  Treatment  of the unprimed  T 
cells from I-J  k mice (B10.A)  with anti-I-J  k (line 4), anti-Thy-1  (line 5), anti-Ly-2  (line 
7),  or anti-Ly-1  (line 8)  antisera  plus  C'  ablated  their  contrasuppressive  activity.  In GERSHON ET AL.  1537 
addition,  mixtures  of independently  treated  anti-I-ff  and  anti-Thy-l-treated  cells 
(line 6), as well as mixtures of anti-I-ff and anti-Ly-1- or anti-Ly-2-treated cells (data 
not  shown),  did  not  reconstitute  contrasuppressive  activity, suggesting that  the cell 
responsible for the contrasuppressive activity expressed all four of these alloantigens. 
It  also  expresses  the  Qa-1  alloantigen  (data  not  shown).  Data  from experiment  III 
show that an I-if-bearing cell also interferes with Ly-2 suppressive activity in a second 
strain  (B6)  (line  10) and verifies the specificity of the anti-I-J  k antiserum  (line 9). For 
the  sake  of simplicity,  we  will  hereafter  refer  to  the  T  cell  that  interferes  with 
suppressive activity as an "Ly-l,2;I-J  ÷ contrasuppressor cell." 
I-J  and Ly-2 Markers  Distinguish  Contrasuppressor  T  Cells from  Helper  T  Cells  (Table 
II).  The  observation  that  Ly-1  T  cells  fail  to  overcome  Ly-2  T  cell-mediated 
suppressive  activity  (Table  I,  line  7)  suggested  that  the  observed  inhibition  of 
suppression could not be accounted for by a simple excess of helper cell activity. Two 
other lines of evidence support this conclusion. First, aliquots of the same Ly-1 T  cells 
that  could  not  overcome suppression  (see  Table  I,  line  7)  exhibited  strong  helper 
activity  when  added  to purified  B  cells  (Table  II, line  3).  Second,  antM-J  plus  C' 
treatment  had no effect on helper activity (Table II, line 4), although this treatment 
eliminated  the  contrasuppressor  cell  (Table  I,  line  4).  Thus,  Ly-l,2;I-J  +  T  cells 
mediate contrasuppressive  activity, whereas  the Ly-l+,2-;I-J  -  T  cells  that  induce  B 
cells to make antibody do not. 
Further  Evidence for a  T  Cell Subset  That Interferes with Ly-2 Suppressor  T  Cell Activity 
(Studies with a Cell-free Product)  (Table Ill).  Confirmation of the above observations 
comes from experiments conducted with biologically active cell-free products obtained 
from antigen-stimulated  Ly-2 T  cells  (Materials  and Methods).  Addition of a  super- 
nate from cultured-primed  Ly-2 cells to fresh cultures containing unprimed unfrac- 
tionated T  cells plus B cells did not suppress helper activity and thus appeared to lack 
suppressive activity (Table III, lines  1 and 2). However, addition of the same amount 
TABLE II 
I-J and Ly-2 Markers Distinguish Contrasuppressor Cells From Helper Cells 
5 X l0  s  2 ×  10  s unprimed T 
cells treated with*  unprimed  Comments 
B cells~: 
PFC/cul- 
ture 
1.  No cells added  100 
2.  NMS + C'  2,200 
3.  Anti-Ly-2 + C'  2,100 
4.  Anti-I-J  ~ + C'  2,100 
5.  Anti-Thy-1 + C'  400 
6.  Anti-Thy-I + C'  500 
Negative control 
Positive control  Helper T cells induce B cells to produce 
antibody. 
Help.  Helper T cells are not killed by anti-Ly-2; the same 
treatment  eliminated contrasuppressive activity (Table 
I, line 7). 
Help.  Helper T cells are not killed by anti-I-J; the same 
treatment  eliminated contrasuppressive activity (Table 
I, line 4). 
Marginal help.  Helper T cells are killed by anti-Thy-l. 
Marginal help.  Helper T cells are killed by anti-Ly-1. 
* Aliquots of Ig-plate-nonadherent B I0.A spleen cells utilized in Table I, experiment I. Anti-I-J  k, B 10.A(3R) 
anti-B 10.A(5R) (ASM-  19). 
:l: All cultures contain  unprimed  anti-Thy-I  plus C'-treated  spleen cells (B cell source). Mean  PFC of 
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TABLE III 
Further Evidence  for a T Cell Subset That Interferes with Ly-2 Suppressor T Celt Activity (Studies with 
Cell-free Material (Factor[s]) 
Factor(s) 
from 
primed  5 ×  106 unprimed 
Ly-2 T  spleen cells treated 
cells  with$ 
added to 
cultures* 
PFC/culture§ 
Exp. I  Exp. 
II 
Comments 
1.  --  NMS + C'  1,700  1,300  No suppression. 
2.  +  NMS + C'  1,700  1,200 
3.  -  Anti-Ly-2 + C'  1,700  900 
4.  +  Anti-Ly-2 + C'  300  300 
Suppression.  Removal of an Ly-2  ÷ ac- 
ceptor cell reveals latent suppressive 
activity in factor preparation. 
5~  -  Anti-I-J  b + C  ND  800  Suppression. Removal of an I-J  + accep- 
6.  +  Anti-I-J  b + C  ND  200  tor cells reveals latent suppressive ac- 
tivity in factor preparation 
* Culture supernate  from in vivo primed anti-Ly-I plus C' treated B6 spleen cells (experiment I) or B6AF1 
spleen cells (experiment II). 
:~ B10 spleen cells (experiment I) or B6AF1 spleen ceils (experiment II). 
§ Mean PFC of triplicate cultures. 
of this supernate  to unprimed  and Ly-1 T  cells plus B  cells resulted in a  substantial 
suppression of the PFC  response  (lines 3  and 4).  A  similar suppression was revealed 
when  the  unprimed  T  cells were  treated  with  an  anti-I-J  serum  (lines  5  and  6). 
Because  anti-Ly-2 or  anti-I-J  plus  C'  treatment  of the  unprimed  spleen  cells was 
required  for  the  expression  of the  suppressive  activity, it  can  be  concluded  that  I- 
J+;Ly-2  +  contrasuppressor ceils in  the unprimed T  cell preparation  interfered with 
the suppressive activity mediated by the cell-free products of Ly-2 suppressor T  cells. 
These  results provide evidence that  suppressive activity can  be inhibited at  a  stage 
distal  to  the  generation  of  Ly-2  suppressor  effector  cells  and  the  release  of their 
biologically active mediators. 
In sum, the data presented show that (a) Thy- 1  +; Ly- 1,2; I-J  ÷ contrasuppressor cells 
interfere with  Ly-2 suppressor cell activity;  (b)  this contrasuppressive activity is not 
produced by Ly-l+,2-;I-J  -  helper T  cells; and  (c)  contrasuppression can occur after 
the generation of suppressor effector cells. Although the precise mechanism by which 
contrasuppression is brought about remains to be resolved, it is clear that the activity 
which we have described is distinguishable from activities previously associated with 
either helper or suppressor systems. 
An I-J+; Ly-2 T  Cell Subset Is Required for the Induction of Contrasuppressive Activity (Table 
IV).  The biological activity of Ly-1,2 T  cells, which is the phenotype of the cell we 
have found to be responsible for contrasuppression, depends, to a  large degree, on the 
nature  of the  inducing  signal  they  receive  (5). 5 Therefore,  we  looked  to  see  if (a) 
Ly-2 T  cells act to induce Ly-1,2 T  cell-dependent contrasuppression, and if so, (b) if 
contrasuppressor-inducing activity and suppressor activity are mediated by separate 
6 Yamauchi, K., D. B. Murphy, H. Cantor, and R. K. Gershon. Analysis of antigen specific, Ig restricted 
cell-free material made by I-I+;Ly-1 cells (Ly-l;TsiF) that  induces  Ly-2  + cells to  express suppressive 
activity. Manuscript  submitted for publication. GERSHON  ET  AL.  1539 
subsets  of Ly-2 T  cells.  Because  the  expression of I-J-controlled markers  had  been 
successfully used to separate different types of Ly-1 inducer T  cells (Introduction), we 
tried to determine if the cellular expression of I-J could also be used to identify these 
potentially different Ly-2 T  cell subsets. We found that  3  ×  10  4 antigen-stimulated 
Ly-2 T  cells could suppress the response of unprimed Ly-1 T  and B  cells (Table IV, 
line 2), but  that  this suppressive activity was  abrogated by the addition of 2  ×  10  5 
unprimed T  cells to the assay cultures (line 3). However, if the antigen-stimulated Ly- 
2 T  cells were treated with anti-I-J plus C', they could act as potent suppressor cells 
even in the presence of 2  ×  10  5 unprimed T  cells (lines 4 and 5). Thus, the activity of 
the  Ly-l,2;I-J  +  contrasuppressor  T  cells  described  above  is  not  autonomous.  An 
inducing signal from antigen-stimulated Ly-2 T  cells is required to make their activity 
manifest. This  inducing signal does not  come from  the Ly-2 suppressor T  cell itself 
(which is I-J-) but rather from a  second Ly-2 cell subset  (contrasuppressor inducer) 
that expresses an I-J marker. Whether Ly-2 suppressor T  cells lack detectable amounts 
of all  I-J  products  or  bear  an  I-J-subregion  product  not  detected  by our  antisera 
remains to be determined. 
Cells with the Contrasuppressor-inducer Phenotype (I-J+; Ly- 1-,2 ÷) Produce a Cell-free Product 
That Has the Same Activity as Contrasuppressor-inducer Cells  (Table V).  To further clarify 
the  role of I-J+;Ly-2 T  cells in  the  contrasuppression  system, we  asked  if cell-free 
TABLE  IV 
An I-J+;  Ly-2 T Cell Subset Is Required  for the Induction of Contrasuppressive Activity 
106 un- 
2 X l0  s  primed 
3 X 104 primed Ly-2  unprimed  Ly-1  T 
T cells treated with*  T cells:]:  and B 
cells 
Comments 
l. 
2. 
3. 
4. 
PFC/culture 
No cells added  -  1,800  Control.  Ly-I T  cells induce  B cells to pro- 
duce antibody. 
NMS + C'  -  100  Suppression. Primed  Ly-2  T  cells  suppress 
helper activity. 
Anti-I-J  k  +  1,300  Marginal  suppression.  Primed Ly-2 T cells in- 
abs. 5R + C'I[  duce  eontrasuppressor  T  cells  to  inhibit 
suppression. 
Anti-I-Jk+ C'  +  100  Suppression.  Anti-I-J treatment kills primed 
Ly-2 T cells which indu~ze  contrasuppressor 
cells, but does  not kill primed Ly-2 suppressor 
T cells. 
Anti-I-J  k  +  100  Suppression. I-J  b strain fails to absorb  anti- 
abs. 3R + C'¶  body reactive with I-J  k primed Ly-2 T cells 
which induce contrasuppressor cells (speci- 
ficity control). 
* Ig-plate-nonadherent B10.A spleen cells cultured for 4 d with SRBC, and treated with anti-Ly-I plus 
complement. 
:~ (-) without or (+) with Ig-plate-nonadherent  spleen cells. 
§ All cultures contain 10  s anti-Ly-2 plus C'-treated unstimulated spleen cells (Ly-1 T cells and B cells). 
Mean PFC of triplicate cultures. 
II BI0.A(3R)  anti-B10.A(5R)  (ASM-18) absorbed with  B10.A(5R)  (I-J k) cells (NMS  equivalent).  This 
serum should not contain anti-I-J activity. 
¶ BI0.A(3R)  anti-B10.A(5R)  (ASM-18) absorbed with B10.A(3R) (I-J  b) ceils. This serum should contain 
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material from antigen-primed Ly-2 T  cells could induce the same contrasuppressive 
activity as the cells. We found that like the producer cells (Table III) the addition of 
some factor(s) from antigen-stimulated Ly-2 T  cells did not suppress the response of 
unprimed unfractionated spleen cells (Table V, line 4), whereas factor(s) derived from 
an aliquot of the same cells that had been treated with anti-I-J plus C' did suppress 
the  response  (Table  V,  line  5).  Thus,  an  I-J-;Ly-2  T  cell  produces  material  that 
suppresses  the expression of helper activity but  does  not  induce  contrasuppression, 
whereas  the  product  of  I-J+;Ly-2  T  cells  induces  Ly-l,2;I-J  +  T  cells  to  display 
contrasuppressive activity. 
Further Evidence  That the Ly-2 T  Cell Responsible for Delivering  a Suppressive  Signal Can Be 
Separated from the Cell That Activates Contrasuppression  by  Virtue of Differential Expression  of 
I-J Subregion-controlled  Products  (Table  VI).  In the experiments depicted in Table VI, 
biologically active cell-free products were obtained from antigen-stimulated, non-anti- 
I-J-treated  Ly-2 T  cells  (see  Materials and  Methods  and  Table  III). However,  the 
products were passed through  an  anti-I-J immunoabsorbent.  This maneuver turned 
a  moderately suppressive factor(s) to a  much more potent suppressive factor(s). Thus 
an I-J+;Ly-2  + T  cell (Table V),  produces an  I-J  ÷ product  that  can  activate contra- 
suppressor cells. These activated cells can obscure the suppressive activity of I-J-; Ly- 
2 T  cells and their products. 
Studies  on  the  Specificity  of the  I-J  ÷ Factor  That Activates  Contrasuppressor  Cells  (Table 
VII).  Previous studies have shown  that the suppressor factor(s)  made by I-J-;Ly-2 
TABLE V 
Cells with the Contrasuppressor-inducer Phenotype (I-J+; Ly-l-,2  ÷) Produce Cell-free Material That Has 
the Same Activity as Contrasuppressor-inducer Cells 
Factor(s) from  5 ×  10  ~ unprimed  PFC/culture§ 
primed Ly-2 T cells  spleen cells 
treated with*  treated with:~  Exp. I  Exp. II 
Comments 
1.  No factor(s) added  NMS + C'  1,300 
2.  No factor(s) added  Anti-Ly-2 + C'  1,300 
3.  NMS + C'  Anti-Ly-2 + C'  350 
4.  NMS + C'  NMS + C'  800 
5.  Anti-I-J + C'  NMS + C'  400 
1,700  Control. Unprimed T cell induce B 
cells to produce antibody. 
1,700  Control. Anti-Ly-2  treatment  has 
no effect on helper activity. 
300  Suppression. Primed  Ly-2 T  cells 
produce  a  factor(s)  that  sup- 
presses helper activity. 
1,700  Marginal  or no suppression.  Factor(s) 
from primed Ly-2 T cells activate 
contrasuppressor  T  cells  to  in- 
hibit suppressor activity. 
350  Suppression.  Anti-l-J  treatment 
kills primed Ly-2 T  cells which 
produce  factor(s) that  activates 
contrasuppressor  cells, but  does 
not kill primed Ly-2 T cells which 
produce factor(s) that suppresses 
helper activity. 
* Culture supernate from in vivo primed anti-Ly-1 plus C'-treated BbAF~  spleen cells (experiment I) or B6 
spleen cells (experiment II). Anti-I-J  k, B10.A(3R) anti-B10.A(5R) (ASM-18) used in experiment I. Anti- 
I-J  b, B10.A(5R) anti-Bl0.A(3R) (ASM-5) used in experiment II. 
:~ Bl0 spleen cells used in experiment  I, (BbA)FI spleen cells used in experiment II. 
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TABLE  VI 
Contrasuppressor-inducer Cells Produce I-J + Cell-free Material That Has the Same Activity  as Do The 
Cells 
Factor(s) from primed Ly-2 T  PFC/culture~  Comments 
cells treated with* 
No factor(s) added  1,900 
NMS column filtrate§  900 
Anti-I-J  b column filtrate[I  200 
Control. 
Suppression.  Primed Ly-2 T  cells produce  a  factor 
that is moderately suppressive. 
Increased  suppression.  RemovalofI-J-bindingmaterial 
changes  moderate  suppression  to severe suppres- 
sion, i.e., it removes eontrasuppression. 
* Culture supernate from primed anti-Ly-I plus C'-treated B6 spleen cells. 
:}: Mean PFC of triplicate cultures of unfractionated  B6 spleen cells. 
§ NMS conjugated to Sepharose beads. 
[] Anti-I-J  b (ASM-5). 
TABLE VII 
Antigen Specificity of Contrasuppressor-inducer Factor Is More Cross-reactive Than Is the Ly-2 
Suppressor Factor(s) Specificity 
Factor(s) from primed  PFC/cul- 
Ly-2 T cells treated  ture~:  Comments 
with* 
No factor  2,600  Control. 
No treatment of factor  4,000  No suppression. 
Abs. (HRBC)§  750 
Abs. (BRBC)§  700 
Suppression.  Absorption  with cross reacting  erythro- 
cytes  removes material that  blocks  "latent" sup- 
pression in Ly-2 factor preparations 
Abs. (SRBC)§  2,800  No suppression.  Expected result since suppressive ma- 
terial is SRBC specific. 
* Culture supernatant from primed anti-Ly-1 plus complement treated B6 spleen cells. 
Mean PFC of triplicate cultures of unfractionated  B6 spleen ceils. 
§ Factor preparation absorbed with cells in parentheses. 
cells  can  be  removed  by  absorption  with  specific  antigen,  but  not  with  other 
heterologous erythrocytes.  4 Also, other studies have suggested that suppressive inter- 
actions between  regulatory cells can be inhibited by cross-reactive antigens  (17,  18). 
If the previously noted  interference with  suppression and/or  inhibition of tolerance 
by cross-reacting antigen was related to contrasuppression, one might expect that the 
cells in the contrasuppressor circuit would be more cross-reactive than the cells in the 
suppressor circuit. Thus, we attempted to determine if the contrasuppressor-inducing 
factor made by the I-J+;Ly-2 T  cells could be absorbed by heterologous erythrocytes 
other  than  the  ones  used  to  induce  production  of a  suppressor  factor  from  T  cells 
(TsV). 
The results presented in Table VII demonstrate quite clearly that such is the case. 
In this experiment, both horse erythrocytes (HRBC)  and burro erythrocytes (BRBC) 
removed the contrasuppressor activity and left the SRBC-specific suppressive activity 
intact. This is not a  dose effect because TsF cannot be absorbed with inappropriate 
erythrocytes, even when the dose of TsF is limiting. We can therefore conclude that 
contrasuppressor-inducer material has a  broader specificity than  does the suppressor 1542  CONTRASUPPRESSION 
factor(s). Thus it is possible in those circumstances where suppressed immunological 
reactivity was rescued by cross-reacting or modified antigens, cells in the contrasup- 
pressor circuit may have been involved. 
The specificity of the  nonimmune contrasuppressor cell that  is  activated by the 
primed  inducer  cell  has  been  more  difficult  to  determine.  Clonal  deletion  type 
experiments must be done to ascertain the specificity of this type. We are presently 
attempting to address this important question. 
It  is  important  to emphasize  that  our results  do not  indicate that  Ly-2 T  cells 
cannot suppress the response of unfractionated spleen cells. It is just that it is an easier 
task to accomplish when the cells in the contrasuppressor circuit are removed. The 
data we have chosen to present best illustrate this point. 
Discussion 
The  data  presented  show  that  antigen-stimulated  I-J+;Ly-2  T  cells  produce  a 
biologically active cell-free product (factor) that induces unprimed Ly-l,2;I-J  + T  cells 
to inhibit the suppressive activity mediated by antigen-stimulated I-J-;Ly-2 T  cells. 
Because  (a)  the  net  effect of this  cellular  interaction  is  inhibition  of suppressive 
activity, and (b) excess helper activity cannot account for this inhibition, the phenom- 
enon can best be described by the term "contrasuppression." Thus, Ly-2;  I-J  + inducer 
T cells, the cell-free product that they produce, and Ly-1,2; I-J  + T cells are components 
of a contrasuppression system or circuit.  (The effector cell in this circuit is probably 
an Ly-1;I-J  + T  cell.  6) The ability of contrasuppressor cells to block the activity of a 
suppressive cell-free product, produced by I-J-;Ly-2 suppressor T  cells, shows  that 
contrasuppression can be effected even after the generation of suppressor effector cells 
and release of their biologically active products. 
The  key differentiation marker  utilized  to distingish  components of the  contra- 
suppression  circuit  from those  of helper or suppressor  circuits  is  an  I-J-subregion- 
controlled determinant. Thus, both the Ly-2 inducer cell and the Ly-l,2 acceptor T 
cells in the contrasuppressor circuit, but not Ly-2 suppressor effector T  cells or helper 
T cells,  7 bear an I-J determinant detected by our reagents in our systems. In addition, 
preliminary data  (D. B. Murphy, unpublished observations)  show that  an anti-I-J  k 
reagent  (ASM-19), which kills  Ly-l,2 contrasuppressor T  cells,  does not  kill  the  I- 
J+;Ly-l,2  T  ceils  in  the  feedback  suppression  circuit  (7).  These  studies  therefore 
provide further evidence for genetic and  serologic complexity of the I-J subregion, 
and suggest that different I-J subregion determinants are expressed in T  cell subsets 
in the contrasuppression and suppression circuits. 
Besides documenting a  heretofore uncharacterized immunoregulatory interaction, 
the results we have presented make several other interesting points. For example, they 
6Green,  D.  R.,  D.  D.  Eardley,  A.  Kimura,  D.  B.  Murphy,  K.  Yamauchi,  and  R.  K.  Gershon. 
Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an 
effector cell in the contrasuppressor circuit. Manuscript submitted for publication. 
7 The reason why we cannot demonstrate I-J+;Ly-1 helper T  cells (19) or helper factors (20) is not clear, 
but may have something to do with the nature of the antigens studied as suggested by Howie et al.  (20). 
Alternatively, the apparent helper function these authors have described is in reality not a  result of helper 
function. We have shown that I-J antisera can remove apparent helper activity in some instances. However 
in those instances, if suppressor cells were removed from the system, the helper cell signal was not affected 
by the I-J antisera. Thus, the actual functional helper cell was I-J- and I-J + contrasuppressor cells were 
required  for I-J-  helper activity to be come manifest (G.  M.  Iverson, D.  R. Green, W.  Ptak, and R. K. 
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show an elegant symmetry in the immunoregulatory apparatus.  As previous studies 
have  shown  (4,  5),  the  majority of cells  that  express  the  Ly-l+,2  -  phenotype are 
programmed to induce immunological effector cells that make a positive contribution 
in the immune response, e.g., they induce cells to make antibody, effect delayed-type 
hypersensitivity responses, and express cytotoxic functions. However, the Ly-1+,2  -  set 
also contains a small subset of I-J  + cells whose function is to activate suppressor cells 
that tend to counteract the positive signals produced by the majority of cells in the 
Ly-1 cell set (7). 
We have now shown a  similar type of functional split in the cells that express the 
Ly-l-,2  + phenotype. Although the predominant function of immunoregulatory Ly- 
1-,2 ÷ cells is to suppress immune responses, they contain an identifiable and separable 
subset that has the job of inducing other cells to counteract the suppressive signal. As 
with the small subset  of Ly-l+,2  -  cells that  is involved in inducing an activity that 
opposes the predominant activity of the other cells in the set  (e.g., suppression), the 
Ly-1-,2  + cells, which induce the alternative opposing activity (e.g., interference with 
suppression or contrasuppression) also express a gene product(s) controlled by the I-J 
subregion.  As  discussed above, the I-J markers expressed on the cells in suppressor 
circuit and  those expressed on the cells involved in contrasuppression are probably 
controlled by different loci. 
Another surprising  result  is  the  amount  of functional heterogeneity that  can  be 
found in the Ly-l-,2  + T  cell set. Although this T  cell set represents <10% of the T  cell 
pool,  it  contains  at  least  four subsets  with  distinct  functions;  (a)  killer cells;  (b) 
suppressor cells;  (c) cells that amplify suppressor activity (8-10);  and  (d)  the subset 
we  have described in  this  report, which acts  to induce other cells to countermand 
suppressor signals. Two of these cell subsets (e.g., the cells involved in contrasuppres- 
sion and those that amplify suppressor activity) have not yet been clearly separated 
by criteria  other  than  function, although  preliminary  data  indicates  that  Qa-1  is 
present  on  the  former but  not  the  latter  cell subset  (10).  These two  functionally 
distinct Ly-l-,2  + subsets can be distinguished from the other two Ly-l-,2  + cells (e.g., 
killer and suppressor cells) by the I-J subregion-encoded antigens that are expressed. 
The question of the biological significance of the contrasuppressive activity we have 
described must be addressed. The results indicate that there are at least two separate 
modes by which suppressor cell activity can be regulated. Previous results have shown 
that the activation of suppressor T  cells is under control of an Ly-1 inducer cell (7, 17, 
21). The results we have presented show that even after the Ly-l-,2  + suppressor cell 
is activated, its ability to perform suppressive functions can be controlled by a closely 
related cell which induces contrasuppressive activity. 
This being the case,  the question of why Ly-l-,2  + suppressor cell activity needs 
more than one level of regulation arises. One could hypothesize that because the Ly- 
1-,2  ÷ suppressor cell needs an  Ly-1  partner inducer cell, it  could  be regulated  by 
suppressing  its own inducer cell that  at  least  in  theory should lead to a  fall off in 
suppressor activity. Almost certainly, this series of regulatory interactions does operate 
during the immune response  (22).  Still,  another level of regulation  that  might  act 
more quickly and  efficiently would be one that  interferes with  the  message of the 
suppressor  cells,  without  waiting  for  the  inactivation  of the  inducer  cell  and  the 
subsequent return to homeostasis. The contrasuppressor cell could perform this role. 
This type of rapid  counteraction of suppression could give the system  increased 1544  CONTRASUPPRESSION 
flexibility.  In  addition,  it  is  a  mechanism  by which  microenvironmental  immune 
regulation could be brought about. Thus, if there was a special anatomical site where 
high levels of immune activity were needed (for example, in the gut) the local release 
of an  activator of the  contrasuppressor circuit  could  allow  for this,  while  keeping 
systemic  immunity  relatively  suppressed.  In  the  example  chosen  for  illustration 
(regulation of immune responses in the lymphoid tissue of the gut), this latter point 
would be of some importance, as  suppressed  systemic immunity could act  to help 
prevent  anaphylactic  or  immune  complex  reactions  caused  by  nontoxic  antigens 
entering the blood from the  intestines.  In  line with  this  notion, we  have obtained 
evidence that Peyer's patches contain particularly high numbers of contrasuppressor 
inducer cells (J. Gold, D. R. Green, and R. K. Gershon, manuscript in preparation). 
Another important situation where microenvironmental immune regulation such 
as the type we envision for contrasuppression might be important would be at sites 
where pathogenic viruses are multiplying and  interferon is being released.  We are 
presently testing the possible role of interferon as an  inducer of contrasuppression. 
Thus, the level of systemic immunity could be set at a  certain mode by suppressor 
mechanisms, and yet allow effector cells to escape from this suppression or regulation 
in certain mieroenvironments where high levels of immune activity are required. 
Another possible role for the cellular interaction we have described stems from the 
need of the immune system to be able to respond, in a secondary fashion, even when 
suppressive elements that are sufficient to interfere with a primary response may be 
present.  Thus,  the  cell  interaction  that  we  have  described,  which  interferes  with 
suppression,  may be crucial  for the expression of at  least  some secondary immune 
responses. 
The antigenic specificity of the cells in the contrasuppressor circuit remains to be 
fully characterized. The increased cross-reactivity (of the inducer factor(s)  (visa vis 
suppressor-inducer  or  suppressor  factors)  is  intriguing.  This  observation  makes  it 
worthwhile to reexamine the old experiments showing that cross-reacting or modified 
antigens  are inimical to tolerance production or maintenance  (18,  19, 23)  to see of 
these phenomena were produced by the activation of the contrasuppressor circuit. 
Considerably  more  data  is  needed  before  the  importance  of the  suppression- 
interfering  activity  (contrasuppression)  that  we  have  described  can  be  assessed. 
However, at least in theory, it offers potentially highly effective way by which several 
important immunological attributes could be controlled. 
Summary 
We  have  described  an  interaction  between  two  T  cell  subsets  that  results  in 
interference with the expression of Ly- 1-,2  + (Ly-2) T  cell-mediated suppression. We 
refer  to  this  novel  immunoregulatory  activity  as  contrasuppression.  The  T  cell 
responsible for the induction of contrasuppression (inducer cell) expresses the pheno- 
type Ly-l-,2+;I-J+;Qa-1 +,  This phenotype distinguishes  it from suppressor effector 
cells which we find to be I-J-. 2' ~ An I-J  + soluble mediator from the contrasuppressor 
inducer cell  acts  on  another cell  (acceptor cell)  that  expresses  the  phenotype  Ly- 
l+,2+;I-J+;Qa-1 +.  This  phenotype  distinguishes  it  from  T  helper  cells.  Both  the 
inducer cell (or its biologically active mediator) and its acceptor cell are required for 
the  expression of contrasuppression.  Because contrasuppressor cells  can  block the 
suppressive  activity of cell-free mediators  released  by Ly-2 suppressor  T  ceils,  the GERSHON  ET AL.  1545 
mechanism of contrasuppression is either separate from or in addition to the inacti- 
vation of suppressor cells themselves. The  potential importance of contrasuppressor 
activity  in  the  regulation  of suppressor  T  cell  activity  in  allowing  immunologic 
memory to be expressed and in permitting microenvironmental immune regulation is 
discussed. 
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